Results for the period ended on 31/12/2025 alongwith limited review report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved un-audited Q3 FY26 (quarter ended Dec 31, 2025) and 9M FY26 results. Standalone revenue from operations fell sharply to Rs 7,467.28 lakhs vs Rs 11,049.53 lakhs in Q3 FY25, a drop of about 32% YoY. On a 9-month basis, revenue crashed to Rs 25,088.20 lakhs from Rs 74,968.37 lakhs last year, a steep ~67% decline. The company slipped into a standalone net loss of Rs 26.90 lakhs in Q3 (vs Rs 26.05 lakh loss YoY), while consolidated loss was Rs 29.61 lakhs. 9M FY26 consolidated result moved into a Rs 5.86 lakh loss against a Rs 485.33 lakh profit a year ago. The auditor (OP Bagla & Co LLP) issued an unmodified limited review report, but the UDIN was left blank due to a technical error on the ICAI portal and will be re-uploaded. The company also flagged that an ICD borrower has defaulted on interest and principal repayment and recovery action has been initiated.
Sharply falling revenues and a return to losses indicate serious business stress; combined with the ICD default and missing UDIN, this is likely to weigh negatively on investor confidence and the stock in the near term.